Amany Afheem
Tanta, Egypt
NCT Number: NCT04335955
Platelets (PLT), a major and essential constituent of blood, plays an important role in physiological and pathological processes such as coagulation, thrombosis, inflammation and maintenance of vascular endothelial cells the integrity (1).
Platelet indices are a group of parameters that are used to measure the total amount of PLTs, PLTs morphology and proliferation kinetics (2).
The commonly used PLT indices include PLT count, mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT). The MPV refers to the ratio of PCT to PLT count. PDW is numerically equal to the coefficient of PLT volume variation, which is used to describe the dispersion of PLTs volume (3).
It is well known that platelet indices have been applied in the diagnosis of hematological system diseases. In recent years, it has been discovered that these indices are related to the severity of illness and patients' prognosis. Reduction in PLT count is an independent risk factor for critically ill patients in intensive care unit (4).
In addition, Acute Physiology and Chronic Health Evaluation II (APACHE II) System also includes thrombocytopenia as an independent risk factor for mortality (5).
In a recent research, it will be reported that MPV will be rising with interleukin-6 and C-reactive protein in septic premature infants. MPV has been used as predictor of many inflammatory diseases as MPV significantly higher on both day 1 and day 3 in neonatal sepsis (6).
In addition, in patients with cirrhosis and ascites, elevated PDW and MPV will be accurate diagnostic predictors for ascetic fluid infection (7).
MPV and PDW will be used as biomarkers predicting the development of postoperative sepsis in colorectal cancer patient (8).
All these evidences indicated that PLT indices will be considered as indicator in a series of diseases (9).
Advantages of platelet indices are simple, available, cheap tools and routinely done in the hospital laboratory in all critical ill patients and may be a useful, sensitive tool for diagnosis and monitoring these patients especially in limited resource countries as Egypt. However, whether PLT indices are correlated with procalcitonin in assessment the severity of illness is still under research in septic patients
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Tanta, Egypt
Blood will be drawn from the peripheral vein, arterial or a central catheter for evaluation of whole blood count, C-reactive protein (CRP), and procalcitonin serum levels. This procedure will be done at diagnosis, 3, 7, 14, 21 and 28 days of sepsis.
The following data will be recorded:
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
patients aged 18-65 years ICU stay more than 24 hours septic patients according to Third International Consensus Definitions Septic Shock patients according to Third International Consensus Definitions
Exclusion criteria
Time frame: within 30 days from hospital admission
The correlation between platelet indices and 30 days mortality among critically ill septic patients
Time frame: within 30 days from hospital admission
Correlation between platelet indices and Length of ICU stay (days)
Time frame: within 30 days from hospital admission
Correlation between platelet indices and detection of organs dysfunction
Time frame: within 30 days from hospital admission
Correlation between platelet indices and procalcitonin.
Amany Faheem
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07076732
Cardiovascular Diseases, Heart Diseases
Sohag, Egypt
View Trial DetailsNCT07363122
Diabetes Mellitus, Diabetes Mellitus, Type 2
View Trial DetailsNCT06612385
Platelet Indices, Platelet Ratios
View Trial DetailsNCT07521306
Biomarkers, Infections
Niğde, Niğde Province, Turkey (Türkiye)
View Trial Details